Results 171 to 180 of about 22,723 (239)

Increased Neurotransmitter Release at the Neuromuscular Junction in a Mouse Model of Polyglutamine Disease [PDF]

, 2011
José Luis Pastoriza Rozas, Leonardo Gómez‐Sánchez, Cristina Tomás‐Zapico, José J. Lucas, Rafael Fernández‐Chacón   +4 more
openalex   +1 more source

A peptidylic inhibitor for neutralizing expanded CAG RNA-induced nucleolar stress in polyglutamine diseases. [PDF]

RNA, 2018
Zhang Q, Chen ZS, An Y, Liu H, Hou Y, Li W, Lau KF, Koon AC, Ngo JCK, Chan HYE.   +9 more
europepmc   +1 more source

Transgenic Monkey Model of the Polyglutamine Diseases Recapitulating Progressive Neurological Symptoms. [PDF]

eNeuro, 2017
Tomioka I, Ishibashi H, Minakawa EN, Motohashi HH, Takayama O, Saito Y, Popiel HA, Puentes S, Owari K, Nakatani T, Nogami N, Yamamoto K, Noguchi S, Yonekawa T, Tanaka Y, Fujita N, Suzuki H, Kikuchi H, Aizawa S, Nagano S, Yamada D, Nishino I, Ichinohe N, Wada K, Kohsaka S, Nagai Y, Seki K.   +26 more
europepmc   +1 more source

Tissue Transglutaminase-Catalyzed Formation of High-Molecular-Weight Aggregatesin VitroIs Favored with Long Polyglutamine Domains: A Possible Mechanism Contributing to CAG-Triplet Diseases

, 1998
Vittorio Gentile, Carlo Sepe, Menotti Calvani, Mariarosa Anna Beatrice Melone, Roberto Cotrufo, Arthur J.L. Cooper, John P. Blass, Gianfranco Peluso   +7 more
openalex   +1 more source

Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age [PDF]

, 2013
Amanda G. Mason, Stéphanie Tomé, Jodie P. Simard, Randell T. Libby, Theodor K. Bammler, Richard P. Beyer, A. Jennifer Morton, Christopher E. Pearson, Albert R. La Spada   +8 more
openalex   +1 more source

Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases. [PDF]

Front Mol Neurosci, 2017
Sambataro F, Pennuto M.
europepmc   +1 more source

Nanoscale studies link amyloid maturity with polyglutamine diseases onset. [PDF]

Sci Rep, 2016
Ruggeri FS, Vieweg S, Cendrowska U, Longo G, Chiki A, Lashuel HA, Dietler G.   +6 more
europepmc   +1 more source

Uncoupling the Trade-Off between Somatic Proteostasis and Reproduction in Caenorhabditis elegans Models of Polyglutamine Diseases. [PDF]

Front Mol Neurosci, 2017
Shemesh N, Shai N, Meshnik L, Katalan R, Ben-Zvi A.   +4 more
europepmc   +1 more source

AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models [PDF]

, 2018
Huiling Hong, Alex Chun Koon, Zhefan Stephen Chen, Yuming Wei, Ying An, Wen Li, Matthew Ho Yan Lau, Kwok‐Fai Lau, Jacky Chi Ki Ngo, Chun‐Ho Wong, Ho Yu Au‐Yeung, Steven C. Zimmerman, Ho Yin Edwin Chan   +12 more
openalex   +1 more source

Aggregation formation in the polyglutamine diseases: protection at a cost? [PDF]

Mol Cells, 2013
Todd TW, Lim J.
europepmc   +1 more source